Back to Search
Start Over
Exelixis settles Cabometyx patent litigation with Cipla
- Source :
- PharmaBiz. May 21, 2024
- Publication Year :
- 2024
-
Abstract
- Exelixis, Inc., a globally ambitious oncology company, announced that it has entered into a Settlement and License Agreement (Agreement) with Cipla Ltd. and Cipla USA, Inc. (collectively Cipla). This settlement [...]
- Subjects :
- Cipla Ltd. -- Licensing agreements
Exelixis Inc. -- Licensing agreements
Generic drugs -- Licensing agreements
Biotechnology industry -- Licensing agreements
Drug approval
Pharmaceutical industry -- Licensing agreements
Company licensing agreement
Pharmaceuticals and cosmetics industries
Cabometyx (Medication) -- Licensing agreements
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.794644144